AMAG Pharmaceuticals, Inc. Banner Image

AMAG Pharmaceuticals, Inc.

  • Ticker AMAG
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
AMAG Pharmaceuticals, Inc. Logo Image
  • 201-500 Employees
  • Based in Waltham, Massachussets
AMAG Pharmaceuticals, Inc. operates as a specialty pharmaceutical company that focuses on maternal health, anemia, and cancer supportive care. It markets Makena, a hydroxyprogesterone caproate injection to reduce the risk of preterm birth in women with a singleton pregnancy; Feraheme (ferumoxytol) injection for use as an intravenous (IV) iron replacement therapy for the treatment of ironMore deficiency anemia in adult patients with chronic kidney disease; and MuGard Mucoadhesive Oral Wound Rinse for the management of oral mucocitis/stomatiits and various types of oral wounds.
4.8 / 5.0 (230)

AMAG Pharmaceuticals, Inc. reports have an aggregate usefulness score of 4.8 based on 230 reviews.

AMAG Pharmaceuticals, Inc.

Most Recent Annual Report

AMAG Pharmaceuticals, Inc.
MOST RECENT 2019 Annual Report and Form 10K

AMAG Pharmaceuticals, Inc. does not currently have any hardcopy reports on AnnualReports.com. Click the button below to request a report when hardcopies become available.

Request Information

Older/Archived Annual Reports

AMAG Pharmaceuticals, Inc. Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!